Cargando…
Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)F] PET tracer
A series of novel derivatives exhibiting high affinity and selectivity towards the COX-2 enzyme in the (aza) indazole series was developed. A short synthetic route involving a bromination/arylation sequence under microwave irradiation and direct C–H activation were established in the indazole and az...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211253/ https://www.ncbi.nlm.nih.gov/pubmed/30362376 http://dx.doi.org/10.1080/14756366.2018.1501043 |
_version_ | 1783367296825163776 |
---|---|
author | Elie, Jonathan Vercouillie, Johnny Arlicot, Nicolas Lemaire, Lucas Bidault, Rudy Bodard, Sylvie Hosselet, Christel Deloye, Jean-Bernard Chalon, Sylvie Emond, Patrick Guilloteau, Denis Buron, Frédéric Routier, Sylvain |
author_facet | Elie, Jonathan Vercouillie, Johnny Arlicot, Nicolas Lemaire, Lucas Bidault, Rudy Bodard, Sylvie Hosselet, Christel Deloye, Jean-Bernard Chalon, Sylvie Emond, Patrick Guilloteau, Denis Buron, Frédéric Routier, Sylvain |
author_sort | Elie, Jonathan |
collection | PubMed |
description | A series of novel derivatives exhibiting high affinity and selectivity towards the COX-2 enzyme in the (aza) indazole series was developed. A short synthetic route involving a bromination/arylation sequence under microwave irradiation and direct C–H activation were established in the indazole and azaindazole series respectively. In vitro assays were conducted and structural modifications were carried out on these scaffolds to furnish compound 16 which exhibited effective COX-2 inhibitory activity, with IC(50) values of 0.409 µM and an excellent selectivity versus COX-1. Radiolabeling of this most potent derivative [(18)F]16 was achieved after boron ester release and the tracer was evaluated in vivo in a rat model of neuroinflammation. All chemistry, radiochemistry and biological experimental data are discussed. |
format | Online Article Text |
id | pubmed-6211253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-62112532018-11-05 Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)F] PET tracer Elie, Jonathan Vercouillie, Johnny Arlicot, Nicolas Lemaire, Lucas Bidault, Rudy Bodard, Sylvie Hosselet, Christel Deloye, Jean-Bernard Chalon, Sylvie Emond, Patrick Guilloteau, Denis Buron, Frédéric Routier, Sylvain J Enzyme Inhib Med Chem Research Paper A series of novel derivatives exhibiting high affinity and selectivity towards the COX-2 enzyme in the (aza) indazole series was developed. A short synthetic route involving a bromination/arylation sequence under microwave irradiation and direct C–H activation were established in the indazole and azaindazole series respectively. In vitro assays were conducted and structural modifications were carried out on these scaffolds to furnish compound 16 which exhibited effective COX-2 inhibitory activity, with IC(50) values of 0.409 µM and an excellent selectivity versus COX-1. Radiolabeling of this most potent derivative [(18)F]16 was achieved after boron ester release and the tracer was evaluated in vivo in a rat model of neuroinflammation. All chemistry, radiochemistry and biological experimental data are discussed. Taylor & Francis 2018-10-26 /pmc/articles/PMC6211253/ /pubmed/30362376 http://dx.doi.org/10.1080/14756366.2018.1501043 Text en © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Elie, Jonathan Vercouillie, Johnny Arlicot, Nicolas Lemaire, Lucas Bidault, Rudy Bodard, Sylvie Hosselet, Christel Deloye, Jean-Bernard Chalon, Sylvie Emond, Patrick Guilloteau, Denis Buron, Frédéric Routier, Sylvain Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)F] PET tracer |
title | Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)F] PET tracer |
title_full | Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)F] PET tracer |
title_fullStr | Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)F] PET tracer |
title_full_unstemmed | Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)F] PET tracer |
title_short | Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)F] PET tracer |
title_sort | design of selective cox-2 inhibitors in the (aza)indazole series. chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)f] pet tracer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211253/ https://www.ncbi.nlm.nih.gov/pubmed/30362376 http://dx.doi.org/10.1080/14756366.2018.1501043 |
work_keys_str_mv | AT eliejonathan designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT vercouilliejohnny designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT arlicotnicolas designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT lemairelucas designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT bidaultrudy designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT bodardsylvie designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT hosseletchristel designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT deloyejeanbernard designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT chalonsylvie designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT emondpatrick designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT guilloteaudenis designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT buronfrederic designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer AT routiersylvain designofselectivecox2inhibitorsintheazaindazoleserieschemistryinvitrostudiesradiochemistryandevaluationsinratsofa18fpettracer |